How do you choose the right AI stack when every vendor promises “end-to-end transformation”? Is an enterprise suite truly the safest bet, or can best-of-breed tools deliver greater flexibility without creating chaos? What does it take to build a tech ecosystem that avoids duplication, prevents sprawl, and actually delivers measurable value?

• Compare how pharma and biotech teams balance integration, flexibility, and data ownership when selecting AI and orchestration tools
• Learn how to avoid duplication and tech sprawl while maximizing interoperability across sourcing and contract systems
• Hear best practices from companies that achieved measurable value through smart technology combinations